W. Mahallawi, “Novel bivalent mucosal antigen formulation targeting SARS-CoV-2 and influenza: immunogenicity assessment using zan in vitro human nasal-associated lymphoid tissue model”, pjvs, vol. 29, no. 2, pp. 281–289, Jun. 2026.